© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Avanafil didn’t appear out of nowhere. Scientists started work on newer options for erectile dysfunction not long after sildenafil rewrote the script for men’s health in the late 1990s. Years of trials, chemical tinkering, and strategic partnerships between research labs and pharma giants led to this molecule seeing the light of day. Its development tracked medical trends—less stigma around men’s sexual health, more personalized solutions, stronger demand for short-acting, fast-working drugs. The drive to improve onset, tailor duration, shave off side effects, and sidestep patent bottlenecks meant companies poured real resources into the pipeline. Avanafil joined the prescription world after regulatory rounds in markets like the U.S., Europe, and Asia. These launches showed just how much the pharmaceutical landscape values incremental innovation—often small tweaks with big impacts for patients.
Avanafil isn’t some mystery substance hidden behind complicated jargon. It arrives on shelves mostly under labels like Spedra or Stendra. The active ingredient carries the chemical name Ethyl 4-[[(3-Chloro-4-Methoxyphenyl)Methyl]Amino]-2-[(2S)-2-Hydroxymethyl-1-Pyrrolidinyl]-5-Pyrimidinecarboxylate, but most folks stick to calling it Avanafil. As a phosphodiesterase type 5 (PDE5) inhibitor, it works a lot like its older cousins—relaxing blood vessels and allowing things to flow when and where they need to. That solid reputation for ‘rapid onset’ means the effects arrive soon after swallowing, with most patients reporting results within fifteen to thirty minutes.
This drug comes out of the lab as a white to pale yellow crystalline powder, not unlike many synthetic small molecules. Researchers clock its melting point at around 150–153 °C. Its solubility profile matters—reasonably soluble in organic solvents like methanol and less so in water. LogP values tell chemists how likely it is to sneak through lipid-rich cell membranes, while the molecule’s stereochemistry ensures the right configuration lands at the target spot. Shelf-stability and bioavailability issues shape packaging and dosing, impacting how physicians decide what is best for each patient.
Pharmaceutical-grade Avanafil typically arrives in film-coated tablet form, calibrated in dosages like 50, 100, or 200 mg per tablet. Packaging lists batch number, expiration date, manufacturer details, and relevant regulatory clearance marks. This complies with FDA and EMA guidelines. Each tablet contains specific excipients that influence its breakdown and uptake. Labels warn about possible drug interactions, the importance of not mixing with nitrates, and tips about timing related to meals and alcohol. Production lines must meet strict GMP requirements—failures in this department can wreck a company’s reputation and harm patients who depend on predictably safe medicine.
Synthesizing Avanafil isn’t a high school chemistry experiment. Routes usually begin with prepping a pyrimidine core, which gets functionalized through chlorination and etherification steps. Technicians then tack on the required amine side chains and the pyrrolidine group, all while monitoring stereochemistry. Purification often employs column chromatography, with final crystallization producing a substance pure enough for pharmaceutical use. Yields and process economics matter, as the cost of goods feeds right into the final retail price and shapes who can access the end product.
Each substitution and group transfer in the lab changes Avanafil’s behavior. Early rounds of medicinal chemistry produced dozens of analogues, but researchers zeroed in on side chains that delivered faster onset and milder side effects. Functionalizing the methoxyphenyl and pyrrolidine rings unlocks new derivatives, possibly with broader applications beyond sexual health. These chemical tweaks set off rounds of animal studies, patent filings, and regulatory hurdles. A single atom swap may turn an active compound into an inert one, so teams double-check every change using spectroscopy, chromatography, and crystallographic analysis.
Chemists and sales reps reach for different names depending on audience. Scientific publications feature Ethyl 4-[[(3-Chloro-4-Methoxyphenyl)Methyl]Amino]-2-[(2S)-2-Hydroxymethyl-1-Pyrrolidinyl]-5-Pyrimidinecarboxylate, while pharmacy signs lean on Stendra or Spedra. Behind the scenes, regulatory agencies assign data-rich codes that help track the active pharmaceutical ingredient across supply chains. Batch numbers and CAS numbers (330784-47-9) surface throughout distribution channels. All these aliases point back to the same molecular backbone.
Every dose of Avanafil must meet rigorous standards. Manufacturers adhere to Good Manufacturing Practice (GMP) and Good Laboratory Practice (GLP), ensuring every tablet matches label claims. Contaminant testing, stability studies, and dissolution testing catch problems before they reach patients. Knowledge of handling requirements shields workers from unnecessary exposure, especially for dust or particulate forms during production. Regular equipment validation, staff training, and audit trails give the public and healthcare professionals confidence in this medication’s reliability.
Doctors reach for Avanafil to treat erectile dysfunction in adult men. Shorter time to onset and lower risk of visual disturbance compared to older medications draw in both patients new to therapy and those who’ve switched for tolerability reasons. Some research teams look at other possibilities, from pulmonary hypertension to Raynaud’s phenomenon, though the main application stays planted in sexual health. The drug’s profile fits those seeking rapid response and effective results without needing to plan hours in advance.
Drug development teams keep looking for the next breakthrough, but Avanafil’s unique selling points—fast onset, selectively targeting PDE5, lower potential for food–drug interactions—represent real achievements. Ongoing clinical trials look for expanded indications and population groups who can safely benefit from it. Some studies dig into pharmacogenomics, checking how patient genetics impact drug metabolism and performance. The pipeline includes modified-release forms, fixed-dose combinations, and explorations into generics as patents begin to expire.
Toxicologists design multistage protocols to uncover Avanafil’s safety profile. Acute and chronic dosing in rodent and non-rodent models precede human studies, focusing on dose thresholds, side effect patterns, and any hint of carcinogenicity. Human trials highlight headache, flushing, and nasal congestion as the most common issues, with an eye trained on rare but dangerous effects like priapism or vision changes. Data from post-marketing surveillance feeds right back into labeling updates and safety communication with healthcare providers.
Avanafil’s life cycle keeps evolving, shaped by changes in healthcare policy, generic competition, and personalized medicine. Upcoming years may see more countries approve it, prices drop, and off-label research multiply. Consumer health tech—wearables, digital health trials, real-world evidence platforms—offers new opportunities for tracking outcomes and tailoring therapy to the individual. The anti-stigma movement in men’s health opens new conversations about what sexual wellness means. As insurance systems wrestle with coverage and access, doctors, patients, policymakers, and industry players keep working out what the next chapter looks like for this once-new molecule.
Avanafil carries a reputation as a treatment for erectile dysfunction, often called ED. Many know about older medications in the same family, such as sildenafil or tadalafil, but Avanafil lands in this lineup with stories worth sharing. Doctors looked for something that would work quickly and, importantly, fade out of the bloodstream swiftly to cut down on unwanted lingering effects.
Avanafil belongs to the group of drugs known as PDE5 inhibitors. These drugs block an enzyme called phosphodiesterase type 5, which can restrict blood flow to the penis. By blocking this enzyme, avanafil lets blood move more freely, offering a way to help men get and maintain an erection during sexual activity.
Avanafil’s claim to fame circles around how fast it starts working. Some studies point out that men notice effects within 15 to 30 minutes of taking a dose. In my own practice, patients reported that this timing allowed for less planning and more spontaneity. Longer-acting options can mean waiting over an hour, which sometimes turns out to be a roadblock, especially when desire appears without warning.
The conversation around ED too often avoids the real impact it has on daily life. People close up in embarrassment, or worse, partners feel ignored. Before these treatments, anxiety and frustration took over relationships and self-esteem. Avanafil’s rapid effect and limited duration help couples keep sex a more natural, less stressful part of their lives.
Medical data supports these feelings. Clinical trials, including over a thousand participants, show avanafil helps men across age groups, whether ED stems from diabetes, stress, or other health issues. According to a review published in the British Journal of Clinical Pharmacology, avanafil worked better than a sugar pill for many men, with a tolerable side effect profile. Headaches, flushing, and stuffy nose appeared in some cases, but side effects wore off quickly with the short duration of the drug.
Like any medication that changes blood flow, avanafil can't be used by everyone. Those taking nitrates for chest pain or certain heart medicines run serious risks if they combine these drugs. That can include dangerous drops in blood pressure. Pharmacists and doctors do their best to screen for these situations, but every patient has to speak up about all meds they use.
Some hope new ED drugs mean fewer fakes sold online. Counterfeit medicines can contain anything, endangering health. Open, honest talks with healthcare providers always protect far better than hunting for shortcuts. My patients often just want the confidence to ask for help without feeling shame.
Opening doors to healthier intimacy often begins with better information. Avanafil does more than treat a condition; it gives people another shot at connection, without turning every encounter into medical choreography. More research could help us learn who will get the best results, but the story of avanafil is already changing many lives for the better.
Talking about medication for erectile dysfunction often makes people a bit uncomfortable, but there’s no getting around the impact it has on quality of life. Avanafil stands out because it works faster than some of the older treatments, letting people enjoy a little more spontaneity. Medicine is only as good as how it’s used, though. Misunderstanding directions or rushing things makes side effects more likely or dampens the expected results.
Doctors usually suggest taking avanafil only once per day. It’s not the kind of pill you take every morning or night with your vitamins. Instead, the prescription tells you to take one tablet about 15 to 30 minutes before sexual activity. Swallow the pill whole with a glass of water. Don’t break, chew, or crush it—it’s designed to dissolve in the right place in your body at the right time. Eating a big meal right before taking avanafil could slow it down. From what I’ve seen reading clinical studies and speaking with pharmacists, people often achieve better results on an empty stomach, or at least before a heavy dinner.
Mixing alcohol, grapefruit juice, or certain other medications spells trouble. Alcohol alone doesn’t just dull the senses. It can also lower blood pressure in ways that, mixed with avanafil, may cause you to feel dizzy or lightheaded. Grapefruit juice, on the other hand, interferes with how your liver handles the medication. As a result, your body can end up with too much avanafil, raising the chances for side effects. Those who use nitrates, or medicines called alpha-blockers for blood pressure, shouldn’t use avanafil at all without a green light from their doctor. The mix risks blood pressure dropping to unsafe levels.
I’ve listened to friends talk about embarrassment when they experienced headaches or facial flushing after taking erectile dysfunction medicine. These symptoms often don’t last, but ignoring more serious issues, like vision changes, ringing in the ears, or a painful erection lasting longer than four hours, puts you at risk of permanent harm. People sometimes brush off these signs, thinking they’re just part of the experience. Reaching out to a healthcare provider can spare you bigger problems down the road.
Pills like avanafil have gained a lot of online attention, with unregulated sellers promising “fast action” pills shipped to your door. The FDA warns consumers not to buy these drugs from unknown sources. Counterfeit drugs have ended up in mailboxes across the country. Real safety comes from a licensed pharmacy and an actual prescription. I’ve seen too many news stories and FDA alerts about medicines laced with harmful powders or ingredients that haven’t been tested.
Open conversations with healthcare providers matter. With avanafil, follow-up visits help make sense of results, side effects, and any lifestyle changes that may help. Simple questions like, "Is this working the way you expected?" or "Have you noticed any unusual symptoms?" make it easier for doctors and patients to team up. Quality of life may start with a prescription, but understanding, communication, and smart choices keep people safer and happier.
Avanafil, sold under the name Stendra, works for men dealing with erectile dysfunction. Like other drugs of its kind, it increases blood flow, making it easier to get and keep an erection. One thing to remember before reaching for any pill—a result comes with trade-offs. No medicine fixes every problem without causing a few of its own.
From what I’ve seen and what researchers have found, most men don’t walk away from avanafil with major problems. Still, even a “mild” side effect matters when you’re the one dealing with it. Flushing pops up as the most common issue. That warm, red face or neck—hardly life-threatening, but still uncomfortable or maybe even embarrassing. Headaches follow close behind. Some guys describe a real pounding that can knock out the romance just as things start to work.
Runny nose and congestion show up on the list too. Imagine planning for intimacy only to spend half the evening sniffling or blowing your nose. Some men feel back pain or muscle aches, like they went to the gym without ever stepping foot inside it. Dizziness isn’t uncommon either, especially if you combine avanafil with alcohol or get up quickly.
Rare complications don’t get as much attention, yet ignoring them proves risky. Vision changes stand out here. Some men report seeing a blue tinge or having trouble with brightness. Sudden hearing loss comes up in published studies, though it seems rare. Chest pain or a racing heartbeat makes the list, surprising some guys who figure a drug for sex only works “down there.”
Mixing avanafil with drugs for chest pain, like nitrates, can drop blood pressure in a hurry—enough to send someone to the ER. This safety message needs repeating for anyone with heart troubles or anyone who takes other prescriptions regularly.
Most side effect data comes from large trials and thousands of real-world users. The FDA did not greenlight avanafil lightly. Still, no two people react exactly alike. Underlying conditions affect outcomes, as do age and even genes. I’ve seen some patients tolerate avanafil well, while others stop after one dose, frustrated by the pounding in their skull.
Doctors often don’t hear about every side effect unless patients bring it up. Many people shrug off flushing or a mild headache. Only the big scares get reported. That reality shapes what we know about safety. So a person’s real-world chances may not always match the textbook list.
A sensible move starts with talking things through with a doctor, including any pills and supplements already on the shelf at home. Read up on risks before starting anything new. Watch for signs that don’t fit the expected pattern, such as sudden vision changes, chest pain, or ringing in the ears. Stop the medicine and call for help if anything serious happens.
Simple steps like drinking plenty of water, timing the dose away from heavy meals, and skipping alcohol on date night can improve the experience for some men. Software is no match for honest conversation, but up-to-date information paired with common sense usually keeps small problems from turning into big ones.
People rarely live with just one health concern. For those figuring out how to manage sexual health alongside heart disease, diabetes, or high blood pressure, adding another drug like avanafil can feel risky. Drug interactions aren’t just a line in the fine print; they remind everyone you don’t take new prescriptions lightly. Many have run into hurdles where a medicine for one problem creates trouble elsewhere.
Avanafil boosts blood flow mainly by relaxing blood vessels, so it can impact blood pressure. This makes it a real issue for folks using nitrates for chest pain or certain blood pressure medications. Combining avanafil and nitrates isn’t just discouraged—it’s flat-out dangerous. Blood pressure can drop sharply, and that can send someone straight to the ER. There’s nothing theoretical about this risk. Emergency doctors have seen these reactions up close. In my own medical training, I saw more than one older man end up in a bad way for thinking a few hours was enough separation between a nitrate and a dose for erectile dysfunction. It isn’t.
Avanafil, a PDE5 inhibitor, becomes a problem with several other common drugs. Nitrates, as mentioned, are top of the list. The FDA and clinical guidelines warn against ever mixing them. Blood thinners, certain antifungal or antibiotic pills (often ending with -azole or -mycin), and medications for HIV can increase avanafil levels in the body. That means more risk for unwanted reactions, headaches, flushing, or worse.
Doctors check for drug interactions before writing out a prescription, but pharmacies still catch misses every day. In a crowded medicine cabinet, it’s far too easy to miss one overlapping risk. Tools like the Drugs.com or Medscape interaction checkers help, but they work best for folks who actually keep precise medication lists and use just one pharmacy.
Most patients don’t have a background in pharmacology or time to cross-reference every refill. Relying on your prescriber to know your medication history helps, but people sometimes forget to mention everything they take, especially those products picked up at health stores or ordered online. Honest conversations at the very start of care, or regular brown bag checkups where every pill bottle gets reviewed, can prevent big mistakes—with avanafil or anything else.
Technology should play a bigger part, linking pharmacy databases or electronic health records. Still, nothing beats plain language from doctors and pharmacists. Instead of rattling off long chemical names, they should explain: “These two together will make your blood pressure nosedive.” That sticks with people more.
If adding avanafil, always double-check for heart pills, blood pressure medications, or anything new from a different provider. Getting ahead of problems usually means fewer ER visits and better quality of life. Making medicine safer comes down to better communication, clear record keeping, and a willingness to stop and ask before adding something new. For most, that’s the best shot at staying out of trouble—and making sure avanafil actually helps instead of hurting.
Avanafil hit the market about a decade ago, promising men a quicker way to get and keep an erection. The promise sounds good, but these pills aren’t right for everyone. After years watching men ask about all kinds of sexual health fixes, one thing stands out: folks need to hear the truth about risks before they start anything.
Some men want to ignore heart problems if it means getting their love life back. Here’s the reality: if someone uses nitrate medicine for chest pain, Avanafil can trigger a dangerous drop in blood pressure. Nitroglycerin, isosorbide, and even some recreational “poppers” fall into this group. Stories around the clinic tell me these warnings sometimes get shrugged off, but this is about more than a ruined evening—it can land a person in the emergency room.
Even guys with weak hearts not on nitrates have to watch out. Heart attacks or strokes in the last six months mean it’s way too risky. The heart won’t handle the extra strain.
Certain drugs interact with Avanafil and ramp up the chance of side effects. Strong versions of antifungals (like ketoconazole), some antibiotics (such as erythromycin), virals for HIV, and the old-school antidepressant nefazodone all make Avanafil stick around too long in the bloodstream. Too much can overwhelm the body. Trust me, no man feels sexy during a pounding headache, dizzy spells, or a blurry-eyed blackout.
Avanafil has to pass through the liver and kidneys, so folks facing severe liver or kidney failure have to steer clear. Their bodies can’t clear the drug fast enough. Slow build-up leads to side effects, which can stack up dangerously over time. From what I’ve seen, patients with mild problems should lean on their doctor—they can adjust the dose, but guessing gets people in trouble.
Visual changes or a sudden loss of vision mean Avanafil must stop immediately. The rare risk of permanent blindness is real. Some people brush off vision changes as no big deal, but once sight goes, it doesn’t come back. Folks with inherited eye diseases (like retinitis pigmentosa) belong in the discussion, too. Good doctors will urge them to pick another solution.
Some men with low blood pressure skip reading instructions or hold off on checkups. Avanafil lowers their pressure more, so blackouts and falls get a lot more likely. Men who’ve had strokes aren’t a fit, either.
The Food and Drug Administration stands behind strict rules for a reason. Not everyone is cut out for Avanafil. Strong, open conversations with your doctor make all the difference. If you’re using pills or patches for blood pressure, have heart troubles, struggle with severe kidney or liver disease, or can’t shake off dizzy spells, Avanafil probably isn’t safe.
After years of seeing men bounce from one option to another, the message remains—talk straight with your provider. Sometimes the best answer comes from a clear talk, not another prescription.
| Names | |
| Preferred IUPAC name | (Ethyl 4-[[3-chloro-4-methoxybenzyl]amino]-2-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]pyrimidine-5-carboxylate) |
| Other names |
Spedra Stendra Zepeed Avana |
| Pronunciation | /əˈvænəfɪl/ |
| Identifiers | |
| CAS Number | 330784-47-9 |
| 3D model (JSmol) | `3D model (JSmol)` string for **Avanafil**: ``` CCCCOC(=O)c1cnc(NCC2CCCN2CO)nc1NCc3ccc(OC)cc3Cl ``` |
| Beilstein Reference | 13638856 |
| ChEBI | CHEBI:77999 |
| ChEMBL | CHEMBL1237021 |
| ChemSpider | 23428621 |
| DrugBank | DB06237 |
| ECHA InfoCard | 07a0a468-ffd9-4c34-903e-3f2d9b94620e |
| EC Number | 201-395-9 |
| Gmelin Reference | 128945 |
| KEGG | D10137 |
| MeSH | D000068622 |
| PubChem CID | 6918809 |
| RTECS number | UJ7K4K267A |
| UNII | 5W7S331F84 |
| UN number | UN Number: Not regulated |
| CompTox Dashboard (EPA) | DTXSID50892449 |
| Properties | |
| Chemical formula | C23H26ClN7O3 |
| Molar mass | 357.82 g/mol |
| Appearance | White to off-white powder |
| Odor | Odorless |
| Density | 1.3 g/cm³ |
| Solubility in water | Slightly soluble in water |
| log P | 2.6 |
| Vapor pressure | Vapor pressure: 4.52E-16 mm Hg at 25°C |
| Acidity (pKa) | pKa = 9.67 |
| Basicity (pKb) | 13.70 |
| Magnetic susceptibility (χ) | -7.2e-6 |
| Refractive index (nD) | 1.515 |
| Dipole moment | 5.16 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | Std molar entropy (S⦵298) of Avanafil: 552.8 J·mol⁻¹·K⁻¹ |
| Pharmacology | |
| ATC code | G04BE12 |
| Hazards | |
| Main hazards | May cause respiratory irritation. May cause eye irritation. May cause skin irritation. |
| GHS labelling | GHS07, GHS08 |
| Pictograms | GHS07, GHS08 |
| Signal word | Warning |
| Hazard statements | Hazard statements: H315, H319, H335 |
| Precautionary statements | Wash hands thoroughly after handling. Avoid release to the environment. Wear protective gloves/protective clothing/eye protection/face protection. |
| NFPA 704 (fire diamond) | NFPA 704: 1-1-0 |
| Flash point | > 291.2 °C |
| LD50 (median dose) | > 1980 mg/kg (rat, oral) |
| NIOSH | 12-7031 |
| PEL (Permissible) | 0.02 mg/m³ |
| REL (Recommended) | 100 mg |
| IDLH (Immediate danger) | Not established |
| Related compounds | |
| Related compounds |
Sildenafil Tadalafil Vardenafil Udenafil Mirodenafil Lodenafil Zydena |
